BioIVT boosts ‘rapidly growing’ immune cell business
BioIVT recently acquired Gray, TN-based PPA Research Group, a human hematologic product provider established in 2009.
The addition will see BioIVT's immunology and disease-state product portfolios expand ‘significantly,’ according to the company, which also in August of this year acquired Hatboro-PA-based Keystone Biologicals, which supplies disease-state plasma, sera, and controls.
Dr. Courtney Noah, vice president of marketing at BioIVT, told us PPA will be integrated into to the company’s ‘rapidly growing’ immune cell business unit.
“We are excited to add PPA’s capabilities in supplying leukopaks collected from a reliable, recallable donor network to meet our ever-increasing client needs,” she said.
As per the agreement – financial terms of which were not disclosed – all of PPA’s employees and its two donor centers in Johnson City, TN and Berkeley, CA will be retained. PPA also operates a nationwide diseased hematologic tissue collection network.
Building on a series of acquisitions, BioIVT also in the second half of 2018 purchased Colmar, PA-based Biological Specialty Corporation and its three donor centers as well as Clinical Trials Laboratory Services' donor center in London, UK.
Additionally, the company implemented Master Control’s International Organization for Standardization (ISO) compliant quality management system (QMS) to manage documentation, auditing, supplier and customer accounts, and risk.
The QMS consolidated and replace computer- and paper-based document control systems used throughout the company’s sites in the US, Europe, and Asia.
